REG - Directa Plus PLC - Exercise of Options

Directa PlusAnnouncement

28/02/2022 17:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220228:nRSb0869Da&default-theme=true

RNS Number : 0869D  Directa Plus PLC  28 February 2022

28 February 2022

 

Directa Plus plc

 

Exercise of Options

Directa Plus (AIM: DCTA) (the "Company"), a leading producer and supplier of
graphene nanoplatelets based products for use in consumer and industrial
markets, announces the exercise of options on 28 February 2022 in respect of a
total of 25,523 new ordinary shares ("New Ordinary Shares") by an employee of
the Company.

 

Application has been made to the London Stock Exchange for the New Ordinary
Shares to be admitted to trading on AIM ("Admission"). It is expected that
Admission will become effective at 8.00 a.m. on 3 March 2022.

 

Following the issue of the new Ordinary Shares, the Company's issued share
capital will comprise 66,057,649 Ordinary Shares. The total number of voting
rights in the Company will be 66,057,649. This figure may be used by
shareholders as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a change to
their interest in, the share capital of the Company under the Disclosure
Guidance and Transparency Rules of the Financial Conduct Authority.

 

 

For further information, please contact:

 

 Directa Plus plc                                            +39 02 36714458
 Giulio Cesareo, CEO
 Giorgio Bonfanti, CFO

 Cenkos Securities plc (Nominated Adviser and Joint Broker)  +44 131 220 6939
 Neil McDonald
 Adam Rae

 Singer Capital Markets Securities Limited (Joint Broker)    +44 20 7496 3069
 Rick Thompson
 Phil Davies

 Tavistock (Financial PR and IR)                             +44 20 7920 3150
 Simon Hudson
 Heather Armstrong

 

 

Notes to Editors

 

Directa Plus (www.directa-plus.com) is one of the largest producers and
suppliers of graphene-based products for use in consumer and industrial
markets. The Company's graphene manufacturing capability uses proprietary
patented technology based on a plasma super expansion process. Starting from
natural graphite, each step of Directa Plus' production process - expansion,
exfoliation and drying - creates graphene-based materials and hybrid graphene
materials ready for a variety of uses and available in various forms such as
powder, liquid and paste.

 

This proprietary production process uses a physical process, rather than a
chemical process, to process graphite into pristine graphene nanoplatelets,
which enables Directa Plus to offer a sustainable, non-toxic product, without
unwanted by-products.

 

Directa Plus' products are made of hybrid graphene materials and graphene
nano-platelets. The products (marketed as G+) have multiple applications due
to its properties. These G+ products can be categorised into various families,
with different products being suitable for specific practical applications.

 

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and
has been listed on the AIM market of the London Stock Exchange since May 2016.
Directa Plus holds the Green Economy Mark from London Stock Exchange which
recognises companies that contribute to the global green economy.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TVRQVLFLLLLZBBL